We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Technical reports related to the investigation of acute hepatitis cases of unknown aetiology that occurred in children in England in 2022.
Update to end of December 2022 on enhanced surveillance of potentially iatrogenic CJD exposures -- occasional reports related to human prion disease surveys.
Weekly statistics taken from the NHS COVID-19 app. This data is no longer being updated.
Results of the policy to minimise time spent in self-isolation after a positive SARS-CoV-2 test result.
Laboratory-confirmed cases of hepatitis A.
Monthly report presenting the latest data on COVID-19 mortality in England in people with laboratory-confirmed SARS-CoV-2.
Results of pilots carried out to assess the value of saliva sampling for coronavirus (COVID-19) testing.
The use of testing within the National Testing Programme (NTP) and answers to questions asked by the media and the public.
The National Testing Programme validated polymerase chain reaction (PCR) kits using spike-in virus samples to test how long a sample could remain in transit.
LFDs have proved vital for detecting SARS-CoV-2 when it is most infectious. This has remained true with new variants including Alpha, Delta and Omicron.
Understanding the impact of repeat routine lateral flow device (LFD) testing of asymptomatic NHS staff in the secondary care patient-facing NHS workforce during the COVID-19 pandemic.
A summary of the historic processes, frameworks and governance across UKHSA ensuring the quality of the COVID-19 testing programme from April 2020 to March 2022.
Qualitative assessment of the risk that tick-borne encephalitis (TBE) virus presents to the UK human population.
An expert panel statement, informed by evidence and expertise, on the role of face coverings in mitigating COVID-19 transmission.
Cumulative data showing the number of GP-registered patients in England having the seasonal influenza vaccine.
Data showing the number and proportion of frontline healthcare workers (HCWs) in England having seasonal influenza and COVID-19 vaccines.
This report describes the extent of infections and injecting-related harms among people who inject drugs (PWID) in the United Kingdom.
Qualitative assessment of the risk of SARS-CoV-2 to human health through non-food exposures to deer in the UK.
Data from laboratories testing for hepatitis and HIV across all UKHSA centre areas of England.
Quarterly reports, with commentary, on cases confirmed by UK Health Security Agency's Virus Reference department or national routine laboratory testing (mumps only).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).